Pomerantz Appointed Co-Lead Counsel in Talis Biomedical Securities Litigation

On June 3, 2022, U.S. District Judge Susan Illston of the Northern District of California appointed Pomerantz LLP as Co-Lead Counsel on behalf of Leon Yu and Max Wisdom Technology Limited – Co-Lead Plaintiffs in the case – and the class, in Modrak v. Talis Biomedical Corporation, 22-cv-105 (N.D. Cal.). This securities action alleges that Talis Biomedical Corporation failed to disclose deficiencies in the testing of its Talis One COVID-19 test (“Talis One”) and the resulting delays with its application to the U.S. Food and Drug Administration (“FDA”) for Emergency Use Authorization (“EUA”). Talis is a medical manufacturing company that focuses on creating “point of care…